Back

Results - Announcements

Sales rise 46.33% to Rs 89.60 crore

Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter

16-May-2026, 07:27
Net profit of Kilitch Drugs (India) rose 39.62% to Rs 14.52 crore in the quarter ended March 2026 as against Rs 10.40 crore during the previous quarter ended March 2025. Sales rose 46.33% to Rs 89.60 crore in the quarter ended March 2026 as against Rs 61.23 crore during the previous quarter ended March 2025.

For the full year,net profit rose 13.00% to Rs 30.17 crore in the year ended March 2026 as against Rs 26.70 crore during the previous year ended March 2025. Sales rose 18.73% to Rs 235.47 crore in the year ended March 2026 as against Rs 198.32 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	89.60	61.23	46	235.47	198.32	19
OPM %	24.72	23.83	-	15.54	15.87	-
PBDT	21.19	14.69	44	42.28	37.58	13
PBT	20.21	13.84	46	38.65	34.47	12
NP	14.52	10.40	40	30.17	26.70	13